fda warning bpc 157 unapproved peptide risks Everything You Need to Know About the Ban US FDA staff highlights peptide

Studies have demonstrated that BPC-157 not only improves tendon healing but also enhances tendon-to-bone integration, even in the presence of corticosteroids, which is notable due to steroids usual effect impairing recovery [53, 59]

In principle, by providing the special characteristics of the muscle-to-bone reattachment in rats after surgical detachment of the quadriceps muscle, these findings accord with and are supported by the healing effects so far reported on the recovery of muscles [30,31,32,33,34], tendons [27,28,29,34,35,36,37], ligaments [38], and bones [39,40,41], as well as injury and osteotendinous [27,28] and myotendinous [13] junction recovery

BPC-157 is on the World Anti-Doping Agency (WADA) Prohibited List under category S0 (non-approved substances)

Helps build more lean muscle mass

Furthermore, the long-term safety profile of these synthetic peptides in humans is not fully understood

Payer bundling policies deserve special attention because they vary widely